title: Serum Quetiapine Concentration Changes with Concomitant Oxcarbazepine Therapy in a Boy with Autism Spectrum Disorder.
authors.affiliation: 1 Department of Pharmacy, Shodair Children's Hospital , Helena, Montana.
authors.forename: Ian R
authors.initials: IR
authors.lastname: McGrane
authors.affiliation: 1 Department of Pharmacy, Shodair Children's Hospital , Helena, Montana.
authors.forename: Joshua G
authors.initials: JG
authors.lastname: Loveland
authors.affiliation: 2 Department of Psychiatry, Shodair Children's Hospital , Helena, Montana.
authors.forename: Heather J
authors.initials: HJ
authors.lastname: Zaluski
authors.affiliation: 2 Department of Psychiatry, Shodair Children's Hospital , Helena, Montana.
authors.forename: Keith D
authors.initials: KD
authors.lastname: Foster
mesh_terms: D000927:Anticonvulsants / Q000494:pharmacology / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000097:blood / Q000627:therapeutic use; D000067877:Autism Spectrum Disorder / Q000097:blood* / Q000188:drug therapy*; D002220:Carbamazepine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D065701:Cytochrome P-450 CYP3A Inducers / Q000494:pharmacology; D004347:Drug Interactions; D016903:Drug Monitoring; D006801:Humans; D008297:Male; D000078330:Oxcarbazepine; D000069348:Quetiapine Fumarate / Q000097:blood* / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D014150:Antipsychotic Agents; D065701:Cytochrome P-450 CYP3A Inducers; D000069348:Quetiapine Fumarate; D002220:Carbamazepine; D000078330:Oxcarbazepine